Elutia (NASDAQ:ELUT) has announced a securities offering to raise approximately $15.0 million. The company entered into a definitive agreement with investors for the purchase and sale of 5.52M shares ...
Annovis Bio (NYSE:ANVS) shares fell around 19% premarket on Monday after the company priced a securities offering to raise $21M. The sale comprises 5.25M shares of common stock and warrants to ...
Elutia (ELUT) announced it has entered into a definitive agreement with investors for the purchase and sale of 5.52M shares of the company’s ...
Annovis Bio (ANVS) announced the pricing of an underwritten public offering of 5.25M shares of common stock and warrants to purchase 5,250,000 ...
MALVERN, Pa., Feb. 03, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies f ...
Palantir's rapid growth doesn't justify its current valuation. Read why PLTR stock is overvalued and why a 30% decline to $60 ...